1-4 of 4
Julia J. Vlasova
Close
Sort by
Journal Articles

Two-Year Updated Results of Asciminib Managed-Access Program (MAP) in Russia

Anna Turkina, Elena A. Kuzmina, Elza Lomaia, Elena Morozova, Oleg A. Shukhov, Anna N. Petrova, Tamara Chitanava, Julia J. Vlasova, Ekaterina Yu. Chelysheva, Evgeniya Sbityakova, Irina S. Nemchenko, Anastasiya V. Bykova, Margarita A. Gurianova, Alina V. Kokhno, Elena N. Parovichnikova
Journal: Blood
Blood (2022) 140 (Supplement 1): 9654–9655.
https://doi.org/10.1182/blood-2022-162268
Published: 2022
Journal Articles

The First Results of Asciminib Therapy in Highly Pretreated Chronic Myeloid Leukemia Patients Under the Managed Access Program (MAP) in Russian Federation

Anna G. Turkina, Oleg A. Shukhov, Elza Lomaia, Elena V. Morozova, Anna Petrova, Ekaterina Yu. Chelysheva, Tamara Chitanava, Julia J. Vlasova, Irina Nemchenko, Anastasiya Bykova, Margarita Gurianova, Andrey Zaritsky
Journal: Blood
Blood (2021) 138 (Supplement 1): 1483.
https://doi.org/10.1182/blood-2021-145712
Published: 2021
Journal Articles

Profile of Checkpoint Molecules Expression on Bone Marrow Cell Populations in Patients with High-Risk Myelodysplastic Syndrome

Nikolai Yu. Tcvetkov, Elena V. Morozova, Olga S. Epifanovskaya, Elena V. Babenko, Maria V. Barabanshikova, Kirill V. Lepik, Eugene A. Bakin, Julia J. Vlasova, Anna G. Smirnova, Axel R. Zander, Ivan S. Moiseev
Journal: Blood
Blood (2020) 136 (Supplement 1): 43–44.
https://doi.org/10.1182/blood-2020-141997
Published: 2020
Journal Articles

The Outcome of Patients with Advanced Phase Chronic Myeloid Leukemia with and without Allogeneic Hemopoietic Stem Cell Transplantation

Elena V. Morozova, Julia J. Vlasova, Maria V. Barabanshikova, Axel R. Zander, Ksenia Jurovskaya, Tatyana L. Gindina, Ildar Barhatov, Sergey N. Bondarenko, Ivan S. Moiseev, Ludmila S Zubarovskaya, MD PhD professor, Aleksandr D. Kulagin, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
https://doi.org/10.1182/blood-2020-139452
Published: 2020